chr20-44160163-G-A
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 2P and 17B. PM2BP4_StrongBP6_Very_StrongBP7BS1
The NM_020433.5(JPH2):c.624C>T(p.Ala208=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000064 in 1,422,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A208A) has been classified as Benign.
Frequency
Consequence
NM_020433.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JPH2 | NM_020433.5 | c.624C>T | p.Ala208= | synonymous_variant | 2/6 | ENST00000372980.4 | NP_065166.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JPH2 | ENST00000372980.4 | c.624C>T | p.Ala208= | synonymous_variant | 2/6 | 5 | NM_020433.5 | ENSP00000362071 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000330 AC: 50AN: 151702Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000906 AC: 4AN: 44172Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 25930
GnomAD4 exome AF: 0.0000315 AC: 40AN: 1270338Hom.: 0 Cov.: 32 AF XY: 0.0000177 AC XY: 11AN XY: 623198
GnomAD4 genome AF: 0.000336 AC: 51AN: 151810Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74208
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 25, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 02, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hypertrophic cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2015 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at